This paper compared HER2 copy numbers as measured by droplet digital polymerase chain reaction (ddPCR) in plasma cell-free DNA (cfDNA) and matched formalin-fixed paraffin-embedded (FFPE) gastric tissue specimens and with HER2 status as determined by immunohistochemical (IHC) staining and silver in situ hybridization (SISH). Correlations between clinicopathological factors and HER2 status were also investigated.
Comparative analysis of HER2 copy number between plasma and tissue samples in gastric cancer using droplet digital PCR.
Kim B, Nam SK, Seo SH, Park KU, Ahn SH, Park DJ, Kim HH, Kim WH, Lee HS
Purpose
Conclusion
A significantly higher number of cases were classified as HER2-negative when HER2 copy number was measured in tissue by ddPCR compared to HER2 status determined by a combination of IHC/SISH. The concordance rate of gastric tissue HER2 status determined by IHC/SISH and ddPCR was 90.0% and the sensitivity and specificity of ddPCR for positive HER2 status IHC/SISH were 85.0% and 95.0%, respectively. The concordance rate of HER2 copy number in plasma cfDNA by ddPCR and tissue IHC/SISH status was 63.75% and the sensitivity, specificity, positive predictive value, and negative predictive value of HER2 status in plasma as determined by ddPCR were 37.5%, 90.0%, 79.0%, and 59.0%, respectively. HER2 copy number as measured by ddPCR of gastric tissue specimens was weakly correlated with the HER2 copy number of matched plasma specimens.
Studies (1)
Purpose
This study compared HER2 copy numbers as measured by ddPCR in plasma cfDNA and matched FFPE gastric tissue specimens and to HER2 status as determined by IHC and SISH. Correlations between clinicopathological factors and HER2 status were also investigated. Tumor tissue specimens were collected from 80 gastric adenocarcinoma patients (18 female, 62 male) undergoing radical gastrectomy with known HER2 IHC status (31 IHC 3+ cases, 19 IHC 2+ cases, and 30 IHC 0 or 1+ cases). Venous blood specimens were collected in EDTA tubes from patients 1–20 days before surgery. Plasma was obtained within 2 h of blood collection by centrifugation at 3000 rpm for 10 min at room temperature and cfDNA was extracted using a High Pure Viral Nucleic Acid Kit. FFPE tissue specimens were prepared by an unspecified method and IHC staining and bright-field dual-color SISH were performed in an autostainer. HER2 status of the FFPE tissues was evaluated with IHC and SISH by a pathologist using standard scoring with IHC scores of 0 and 1+ considered negative, IHC 3+ considered positive, and specimens with IHC score 2+ and SISH score >2.0 were regarded as positive. DNA was extracted from four deparaffinized, 8 μm-thick sections using the QIAamp DNA FFPE Tissue Kit. DNA concentration was determined by NanoDrop. HER2 copy number was determined in plasma cfDNA and tissue DNA by ddPCR of erb-b2 receptor tyrosine kinase 2 (ERBB2) and the reference gene eukaryotic translation initiation factor 2C, 1 (EIF2C1) using a QX200 Droplet Digital PCR System.
Summary of Findings
Based on a combination of IHC/SISH staining, 40/80 gastric tissue specimens were HER2 negative and the remaining 40 cases were HER2-positive but a significantly higher number of cases (44/80) were classified as HER2-negative when HER2 copy number was measured in the FFPE tissue specimen by ddPCR (P<0.001). The concordance rate of gastric tissue HER2 status determined by IHC/SISH and ddPCR in tissue specimens was 90.0% (72/80) and the sensitivity and specificity of ddPCR of FFPE tissue DNA were 85.0% and 95.0%, respectively. Using ddPCR analysis of plasma cfDNA, 61 patients were HER2-negative and 19 were HER2-positive. The concordance rate of HER2 copy number in cfDNA by ddPCR and tissue IHC/SISH status was 63.75% (51/80). The sensitivity, specificity, positive predictive value, and negative predictive value of HER2 status in cfDNA as determined by ddPCR were 37.5%, 90.0%, 79.0%, and 59.0%, respectively. HER2 copy number as measured by ddPCR of DNA from FFPE gastric tissue specimens was weakly correlated with the HER2 copy number of matched plasma cfDNA (r=0.232, P=0.038). HER2-positive IHC/SISH status of tissue specimens was correlated with adenocarcinoma classification (intestinal type and diffuse type, P=0.021) but not ddPCR HER2 copy number in tissue or plasma specimens. However, determination of HER2 status by ddPCR showed significant correlation with advanced gastric cancer (P=0.022), presence of lymphatic invasion (P=0.003), and presence of lymph node metastasis (P=0.036) in DNA from tissue specimens but not matched plasma.
Biospecimens
TissueStomachFluidPlasmaPreservation Types
FormalinNone (Fresh)Diagnoses
NeoplasticCarcinomaPlatforms
DNASpectrophotometryDNADigital PCRProteinImmunohistochemistryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Adenocarcinoma classification typeDepth of tumor invasionLymph node metastasesLymphatic invasionPerineural invasionTumor locationTumor sizeVenous invasionDigital PCR Specific Targeted nucleic acid HER2Immunohistochemistry Specific Targeted peptide/protein HER2Immunohistochemistry Specific Technology platform ddPCR